Delivery Order SPE2DB22D2206-SPE2DB23FHF82
- Not listed
- This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $25,295.68 and an ultimate completion date of September 21, 2023. It is a firm-fixed-price delivery order contract, without any...
- This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $4,728.23 and runs through December 5, 2023. It is a delivery order contract with a firm fixed price pricing type. The award was not set aside for any specific business category....
- This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $23,781.84 and is a firm fixed price delivery order with a completion date of May 13, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution in 120ml bottles to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,707.24 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $2,393.44 and covers the delivery of Cetirizine HCL 1 mg/ml solution in 120 ml bottles. The contract is a delivery order with a firm fixed price, and there is no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has a significant Indefinite...
- This federal contract award is for the delivery of Cetirizine HCl 1 mg/ml solution in 120 ml bottles to the Defense Logistics Agency (DLA). The $1,275.60 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of Cetirizine HCl 1 mg/ml solution, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,051.90, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on September 27, 2023. The contract type is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through...
- This federal contract award is for the delivery of Cetirizine HCL 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,168.23, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of January 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,278.93 for the supply of Cetirizine HCL 1 mg/ml solution. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a performance period that ends on December 28, 2022. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Cetirizine HCL 1 mg/ml solution, a prescription medication, with a ceiling value of $4,137.57 and a completion date of April 25, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FHF82Delivery Order
This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution, a type of medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a ceiling value of $4,117.42 and is a Firm Fixed Price Delivery Order with a completion date of May 19, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 5/18/23 |